Management of obesity.

Am J Health Syst Pharm

Sullivan University College of Pharmacy and Health Sciences, Louisville, KY, USA.

Published: January 2025

Purpose: This review summarizes the comprehensive management of obesity with a focus on the pharmacology, efficacy, and safety of anti-obesity medications.

Summary: Obesity is a highly prevalent chronic disease with significant health risks, requiring a multifaceted approach to treatment. While most approved weight loss medications have modest effects, newer medications such as semaglutide and tirzepatide have shown greater than 15% reduction in baseline weight. Optimal selection of therapy requires taking into consideration patient factors, such as comorbidities and goals, and medication-related factors, including weight loss efficacy, contraindications, and improvements in cardiovascular risk. As the availability of anti-obesity medications increases, multidisciplinary care teams will play an important role in selecting optimal strategies for long-term health benefits in individuals with obesity.

Conclusion: The expanding array of anti-obesity medications provides valuable treatment options alongside lifestyle interventions and surgical approaches for managing obesity and reducing weight-related health risks. As this therapeutic area continues to grow, selecting optimal agents and educating patients on administration, monitoring, and potential adverse effects will be critical for improving overall outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajhp/zxae273DOI Listing

Publication Analysis

Top Keywords

management obesity
8
health risks
8
weight loss
8
anti-obesity medications
8
selecting optimal
8
obesity purpose
4
purpose review
4
review summarizes
4
summarizes comprehensive
4
comprehensive management
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!